AGLAIA BioMedical Ventures BV is a private equity general partner firm headquartered in Bilthoven, Netherlands.
Inthera Bioscience, a Switzerland-based biopharmaceutical company, raised CHF10.5m in Series A from Merck Ventures and others.
Netherlands-based life sciences company Cristal Therapeutics has raised $12.8m from Aglaia BioMedical Ventures and others.
Immune-oncology company Macrophage Pharma has raised £9m in Series A from CRT Pioneer Fund, Novo Seeds and Aglaia Biomedical Ventures.
Read more news concerning AGLAIA BioMedical Ventures BV
A sampling of AGLAIA BioMedical Ventures BV portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?